These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The clinical consequences of heterogeneity within and between different diabetes types. Redondo MJ; Hagopian WA; Oram R; Steck AK; Vehik K; Weedon M; Balasubramanyam A; Dabelea D Diabetologia; 2020 Oct; 63(10):2040-2048. PubMed ID: 32894314 [TBL] [Abstract][Full Text] [Related]
4. Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11. Edghill EL; Flanagan SE; Ellard S Rev Endocr Metab Disord; 2010 Sep; 11(3):193-8. PubMed ID: 20922570 [TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Støy J; Steiner DF; Park SY; Ye H; Philipson LH; Bell GI Rev Endocr Metab Disord; 2010 Sep; 11(3):205-15. PubMed ID: 20938745 [TBL] [Abstract][Full Text] [Related]
7. Monogenic diabetes in Pakistani infants and children: challenges in a resource poor country. Ibrahim MN; Laghari TM; Riaz M; Khoso Z; Khan YN; Yasir M; Hanif MI; Flanagan SE; De Franco E; Raza J J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1095-1103. PubMed ID: 34187112 [TBL] [Abstract][Full Text] [Related]
8. Neonatal diabetes caused by disrupted pancreatic and β-cell development. De Franco E Diabet Med; 2021 Dec; 38(12):e14728. PubMed ID: 34665882 [TBL] [Abstract][Full Text] [Related]
9. Diabetes in very young children and mutations in the insulin-secreting cell potassium channel genes: therapeutic consequences. Flechtner I; Vaxillaire M; Cavé H; Scharfmann R; Froguel P; Polak M Endocr Dev; 2007; 12():86-98. PubMed ID: 17923772 [TBL] [Abstract][Full Text] [Related]
10. Monogenic Diabetes: Genetics and Relevance on Diabetes Mellitus Personalized Medicine. Sousa M; Bruges-Armas J Curr Diabetes Rev; 2020; 16(8):807-819. PubMed ID: 31886753 [TBL] [Abstract][Full Text] [Related]
11. New uses for old drugs: neonatal diabetes and sulphonylureas. Ashcroft FM Cell Metab; 2010 Mar; 11(3):179-81. PubMed ID: 20197050 [TBL] [Abstract][Full Text] [Related]
12. Mutations in the Kir6.2 subunit of the KATP channel and permanent neonatal diabetes: new insights and new treatment. Slingerland AS; Hattersley AT Ann Med; 2005; 37(3):186-95. PubMed ID: 16019717 [TBL] [Abstract][Full Text] [Related]
15. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences. Flechtner I; de Lonlay P; Polak M Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510 [TBL] [Abstract][Full Text] [Related]
16. A successful transition to sulfonylurea treatment in male infant with neonatal diabetes caused by the novel abcc8 gene mutation and three years follow-up. Katanic D; Vorgučin I; Hattersley A; Ellard S; Houghton JAL; Obreht D; Knežević Pogančev M; Vlaški J; Pavkov D Diabetes Res Clin Pract; 2017 Jul; 129():59-61. PubMed ID: 28511139 [TBL] [Abstract][Full Text] [Related]
17. Monogenic Forms of Diabetes Mellitus. Gaál Z; Balogh I Exp Suppl; 2019; 111():385-416. PubMed ID: 31588541 [TBL] [Abstract][Full Text] [Related]
18. A Novel KCNJ11 Mutation Associated with Transient Neonatal Diabetes. Gole E; Oikonomou S; Ellard S; De Franco E; Karavanaki K J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):175-178. PubMed ID: 28943514 [TBL] [Abstract][Full Text] [Related]
19. Monogenic diabetes in children and young adults: Challenges for researcher, clinician and patient. Slingerland AS Rev Endocr Metab Disord; 2006 Sep; 7(3):171-85. PubMed ID: 17186387 [TBL] [Abstract][Full Text] [Related]